Related references
Note: Only part of the references are listed.Therapeutic cancer vaccines
Mansi Saxena et al.
NATURE REVIEWS CANCER (2021)
Breast cancer vaccines: Heeding the lessons of the past to guide a path forward
Cinzia Solinas et al.
CANCER TREATMENT REVIEWS (2020)
Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy
Xu Lei et al.
CANCER LETTERS (2020)
Recent advances in mRNA vaccine technology
Norbert Pardi et al.
CURRENT OPINION IN IMMUNOLOGY (2020)
Self-Amplifying RNA Viruses as RNA Vaccines
Kenneth Lundstrom
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast Cancer
Erika J. Crosby et al.
CLINICAL CANCER RESEARCH (2020)
Cancer immunotherapy via targeted TGF-β signalling blockade in THcells
Shun Li et al.
NATURE (2020)
The Role of the Tumor Microenvironment in Developing Successful Therapeutic and Secondary Prophylactic Breast Cancer Vaccines
Benjamin Gordon et al.
VACCINES (2020)
The neoepitope landscape of breast cancer: implications for immunotherapy
Pooja Narang et al.
BMC CANCER (2019)
mRNA Delivery for Therapeutic Anti-HER2 Antibody Expression In Vivo
Yulia Rybakova et al.
MOLECULAR THERAPY (2019)
Lipid-Based Vectors for Therapeutic mRNA-Based Anti-Cancer Vaccines
Maria L. Guevara et al.
CURRENT PHARMACEUTICAL DESIGN (2019)
A DNA vaccine expressing an optimized secreted FAPα induces enhanced anti-tumor activity by altering the tumor microenvironment in a murine model of breast cancer
Fei Geng et al.
VACCINE (2019)
WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers
Jason J. Luke et al.
CLINICAL CANCER RESEARCH (2019)
Vaccine-Induced Memory CD8+ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study
Erika J. Crosby et al.
CLINICAL CANCER RESEARCH (2019)
Nanoparticles Containing Oxidized Cholesterol Deliver mRNA to the Liver Microenvironment at Clinically Relevant Doses
Kalina Paunovska et al.
ADVANCED MATERIALS (2019)
PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers
Mark Yarchoan et al.
JCI INSIGHT (2019)
Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer
Lina Liu et al.
MOLECULAR THERAPY (2018)
Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
Peter Savas et al.
NATURE MEDICINE (2018)
mRNA vaccines - a new era in vaccinology
Norbert Pardi et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Correlates of immune and clinical activity of novel cancer vaccines
Sjoerd H. van der Burg
SEMINARS IN IMMUNOLOGY (2018)
An RNA toolbox for cancer immunotherapy
Fernando Pastor et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12
Christopher S. Garris et al.
IMMUNITY (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Immunomodulation of the Tumor Microenvironment: Turn Foe Into Friend
Hanne Locy et al.
FRONTIERS IN IMMUNOLOGY (2018)
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
Luc Y. Dirix et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Combined immunotherapy of breast cancer with EGF and VEGF vaccines from DNA shuffling in a mouse model
Dong Jin et al.
IMMUNOTHERAPY (2017)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Ahmet Zehir et al.
NATURE MEDICINE (2017)
Vaccination with High-Affinity Epitopes Impairs Antitumor Efficacy by Increasing PD-1 Expression on CD8+ T Cells
Christopher D. Zahm et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Therapeutic blockade of Foxp3 in experimental breast cancer models
Mariela A. Moreno Ayala et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Low dose cyclophosphamide: Mechanisms of T cell modulation
Mutsa Tatenda Madondo et al.
CANCER TREATMENT REVIEWS (2016)
Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses
Marij J. Welters et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Neoadjuvant administration of Semliki Forest virus expressing interleukin-12 combined with attenuated Salmonella eradicates breast cancer metastasis and achieves long-term survival in immunocompetent mice
M. Gabriela Kramer et al.
BMC CANCER (2015)
Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy
Gianfranco Pasut et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
Sebastian Kreiter et al.
NATURE (2015)
Mutanome Engineered RNA Immunotherapy: Towards Patient-Centered Tumor Vaccination
Mathias Vormehr et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
RNA-Based Vaccines in Cancer Immunotherapy
Megan A. McNamara et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
The ReNAissanCe of mRNA-based cancer therapy
Sandra Van Lint et al.
EXPERT REVIEW OF VACCINES (2015)
Immunogenicity of dendritic cells pulsed with MAGE3, Survivin and B-cell maturation antigen mRNA for vaccination of multiple myeloma patients
Willemijn Hobo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Active immunotherapy for mouse breast cancer with irradiated whole-cell vaccine expressing VEGFR2
Heng-Xiu Yan et al.
ONCOLOGY REPORTS (2013)
Semliki Forest virus biodistribution in tumor-free and 4T1 mammary tumor-bearing mice: a comparison of transgene delivery by recombinant virus particles and naked RNA replicon
J. Vasilevska et al.
CANCER GENE THERAPY (2012)
Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome
Yingzi Ge et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Manipulation of the surface pegylation in combination with reduced vesicle size of cationic liposomal adjuvants modifies their clearance kinetics from the injection site, and the rate and type of T cell response
Randip Kaur et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
Hirokazu Matsushita et al.
NATURE (2012)
Polyclonal HER2-specific antibodies induced by vaccination mediate receptor internalization and degradation in tumor cells
Xiu-Rong Ren et al.
BREAST CANCER RESEARCH (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
High immunogenic potential of p53 mRNA-transfected dendritic cells in patients with primary breast cancer
Ozcan Met et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Cancer immunotherapy comes of age
Ira Mellman et al.
NATURE (2011)
Intranodal Vaccination with Naked Antigen-Encoding RNA Elicits Potent Prophylactic and Therapeutic Antitumoral Immunity
Sebastian Kreiter et al.
CANCER RESEARCH (2010)
Randomized Study of Lapatinib Alone or in Combination With Trastuzumab in Women With ErbB2-Positive, Trastuzumab-Refractory Metastatic Breast Cancer
Kimberly L. Blackwell et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Designer Lipids Advance Systemic siRNA Delivery
Yang Liu et al.
MOLECULAR THERAPY (2010)
A Review of Triple-Negative Breast Cancer
Roohi Ismail-Khan et al.
CANCER CONTROL (2010)
Nanoparticles target distinct dendritic cell populations according to their size
Vania Manolova et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
BLP-25 liposomal vaccine: a promising potential therapy in nonsmall-cell lung cancer
Erin Powell et al.
Expert Review of Respiratory Medicine (2008)
Adoptive cell transfer: a clinical path to effective cancer immunotherapy
Steven A. Rosenberg et al.
NATURE REVIEWS CANCER (2008)
Alphaviral vector-transduced dendritic cells are successful therapeutic vaccines against neu-overexpressing tumors in wild-type mice
Timothy P. Moran et al.
VACCINE (2007)
Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers
Inge Marie Svane et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Human breast cancer cells selected for resistance to trastuzumab in vivo overexpress epidermal growth factor receptor and ErbB Ligands and remain dependent on the ErbB receptor network
Christoph A. Ritter et al.
CLINICAL CANCER RESEARCH (2007)
Endoglin (CD105) is a target for an oral DNA vaccine against breast cancer
Sung-Hyung Lee et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
A novel DNA vaccine encoding PDGFRβ suppresses growth and dissemination of murine colon, lung and breast carcinoma
Charles D. Kaplan et al.
VACCINE (2006)
A measles virus vaccine strain derivative as a novel oncolytic agent against breast cancer
Cari J. McDonald et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835]
Vasso Apostolopoulos et al.
BREAST CANCER RESEARCH (2006)
Cotransfection of dendritic cells with RNA coding for HER-2/neu and 4-1BBL increases the induction of tumor antigen specific cytotoxic T lymphocytes
F Grünebach et al.
CANCER GENE THERAPY (2005)
Prime-boost vaccination with plasmid and adenovirus gene vaccines control HER2/neu(+) metastatic breast cancer in mice
XY Wang et al.
BREAST CANCER RESEARCH (2005)
Dendritic cell infiltration and prognosis of early stage breast cancer
I Treilleux et al.
CLINICAL CANCER RESEARCH (2004)
Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition
C Foged et al.
VACCINE (2004)
Tumor-associated antigens: From discovery to immunity
JD Lewis et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2003)
DNA vaccination against neu reduces breast cancer incidence and metastasis in mice
LB Lachman et al.
CANCER GENE THERAPY (2001)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
